Multicountry Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 07 Jun 2017 Biomarkers information updated
- 02 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.